These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6143907)

  • 21. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man.
    MacNab MW; Foltz EL; Graves BS; Rinehart RK; Tripp SL; Feliciano NR; Sen S
    J Clin Pharmacol; 1984; 24(2-3):76-83. PubMed ID: 6371062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of synergism between dazoxiben and dipyridamole following administration to man.
    Gresele P; Deckmyn H; Arnout J; Zoja C; Vermylen J
    Thromb Res; 1985 Jan; 37(1):231-6. PubMed ID: 3838601
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production.
    Cowley AJ; Jones EW; Hanley SP
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):107S-112S. PubMed ID: 6337600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
    Randall MJ; Wilding RI
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
    FitzGerald GA; Brash AR; Oates JA; Pedersen AK
    J Clin Invest; 1983 Oct; 72(4):1336-43. PubMed ID: 6355181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

  • 27. Dazoxiben-induced changes in the thromboxane/prostacyclin balance in the lateral cochlear wall of the guinea pig.
    Ernst A; Taube C; Lotz P; Mest HJ
    Arch Otorhinolaryngol; 1988; 245(1):50-2. PubMed ID: 3291841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of thromboxane synthetase reduces group-B-beta-hemolytic-streptococci-induced pulmonary hypertension in piglets.
    Hammerman C; Komar K; Meadow W; Strates E
    Dev Pharmacol Ther; 1988; 11(5):306-12. PubMed ID: 3056674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
    Zipser RD
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
    Fischer S; Struppler M; Böhlig B; Bernutz C; Wober W; Weber PC
    Circulation; 1983 Oct; 68(4):821-6. PubMed ID: 6352080
    [No Abstract]   [Full Text] [Related]  

  • 33. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin in pregnancy.
    Spitz B; Deckmyn H; Van Assche FA; Vermylen J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):303-8. PubMed ID: 6441731
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of amrinone: role of thromboxane synthetase inhibition.
    Kinney EL; Draganis T; Luderer JR; Demers LM
    Prostaglandins Leukot Med; 1983 Jun; 11(2):213-24. PubMed ID: 6576389
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
    Ylikorkala O; Pekonen F; Viinikka L
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
    Oates JA; Brash A; Fitzgerald G
    Trans Am Clin Climatol Assoc; 1984; 95():157-62. PubMed ID: 6433527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.